Search Results
Apr 18, 2026, 14:59 ET Best Home Saunas of 2026: 8 Brands Compared by Heat Type, Construction, Safety Data, and Warranty
Indoor only. Cannot produce steam. 165°F max is below the Luminar 2 (170°F) and traditional saunas (195°F).5. Almost Heaven Pinnacle — Best Traditional Barrel Sauna (~$5,995)Specs: Traditional electric (Harvia 6kW) • Max temp: 195°F • Löyly: Yes (water on stones) • Wood: 1-3/8"
More news about: Sun Home Saunas
Apr 18, 2026, 10:44 ET 2025 China & Global Development Reports Published in Hainan
https://mma.prnewswire.com/media/2959780/2c925c679d223fff019d96cf1bf31f3f.jpg
More news about: Hainan International Media Center (HIMC)
Apr 18, 2026, 10:08 ET GAC 테크 데이 2026, 스마트 모빌리티 선도할 5대 핵심 기술 공개
multimedia:https://www.prnewswire.com/kr/news-releases/u0067u0061u0063u002DuD14CuD06Cu002DuB370uC774u002Du0032u0030u0032u0036u002Cu002DuC2A4uB9C8uD2B8u002DuBAA8uBE4CuB9ACuD2F0u002DuC120uB3C4uD560-302746491.htmlSOURCE
More news about: GAC
Apr 18, 2026, 04:31 ET Tech TAILG. Leading Globally: TAILG Showcases at the 139th Canton Fair
models, including electric motorcycles, e-bikes, electric bicycles, and electric tricycles, meeting diverse mobility needs across global markets.The F91 Ultra-L fast-charging model made a key appearance, featuring automotive-grade fast-charging technology and an integrated "vehicle + charging station"
More news about: TAILG
Apr 17, 2026, 22:38 ET 再鼎醫藥公布最新數據，顯示Zocilurtatug Pelitecan (Zoci) 在小細胞肺癌腦轉移患者中實現快速且顯著的顱內緩解，並在其他神經內分泌癌中展現出良好活性
https://register-conf.media-server.com/register/BId10f18579c7947b29fda2857a99f26b9演講人: 再鼎醫藥總裁，全球研發負責人Rafael G. Amado博士；西班牙馬德裡12 de Octubre大學醫院腫瘤內科主任、西班牙國家癌症研究中心（CNIO）肺癌單元負責人Luis
More news about: 再鼎醫藥
Apr 17, 2026, 20:01 ET Zoomlion baut seine lokalen Fertigungs- und Servicekapazitäten aus, während das Werk für Hubarbeitsbühnen in Ungarn den Betrieb aufnimmt
https://mma.prnewswire.com/media/2959013/9b4717d94a8a9005ce21ce3f7dc9b160.jpg
More news about: Zoomlion
Apr 17, 2026, 18:01 ET 歐洲臨床微生物學與感染病學會大會 (ESCMID Global)：英國衛生安全局 (UKHSA) 重大研究發現，孕婦接種呼吸道合胞病毒 (RSV) 疫苗可將嬰兒住院風險降低逾八成
是一種常見病毒，可引致嬰幼兒及兒童出現嚴重呼吸道疾病，包括細支氣管炎及肺炎等下呼吸道感染 (LRTI)。 它是全球各地嬰兒住院的主要原因之一，而早期感染亦可能與長期健康影響相關，包括反覆喘鳴或哮喘、多次入院，以及肺功能受損。英格蘭於 2024 年 9 月 1 日推出全國孕婦 RSV 疫苗接種計劃，為懷孕滿 28 週的孕婦提供二價融合前 F 蛋白 (Bivalent Prefusion F) 疫苗。為評估該疫苗對與 RSV 相關的下呼吸道感染所致嬰兒住院的影響，英國衛生安全局的研究人員利用全國連結數據集進行回顧性隊列研究，數據涵蓋英國國民保健署 (NHS) 產科紀錄、疫苗接種資料，以及醫院及實驗室數據。 分析涵蓋 2024 年 9 月 2 日至 2025
More news about: ESCMID Global
Apr 17, 2026, 18:01 ET ESCMID 글로벌: 영국 보건안전청 대규모 연구, 산모 RSV 백신 접종이 영아 입원 위험을 80% 이상 감소시킨다는 결과 발표
생애 초기 감염은 반복적인 천명이나 천식, 반복 입원, 폐 건강 악화 등 잠재적인 장기적 영향과 연관되어 있다.영국에서는 2024년 9월 1일 국가 산모 RSV 예방 접종 프로그램이 도입되어 임신 28주 이상의 임산부에게 2가 프리퓨전 F 백신(Bivalent Prefusion F vaccine)을 제공하고 있다.RSV 관련 하기도 감염으로 인한 영아 입원에 미치는 영향을 평가하기 위해 영국 보건안전청(UK Health Security Agency, UKHSA) 연구진은 NHS 산부인과 기록, 예방 접종 데이터,
More news about: ESCMID Global
Apr 17, 2026, 18:01 ET ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds
impaired lung health.In England, a national maternal RSV vaccination programme was introduced on 1 September 2024, offering the Bivalent Prefusion F vaccine to pregnant women from 28 weeks' gestation.To evaluate its impact on infant hospitalisations due to RSV-associated LRTI, researchers from
More news about: ESCMID Global
Apr 17, 2026, 18:01 ET ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds
impaired lung health.In England, a national maternal RSV vaccination programme was introduced on 1 September 2024, offering the Bivalent Prefusion F vaccine to pregnant women from 28 weeks' gestation.To evaluate its impact on infant hospitalisations due to RSV-associated LRTI, researchers from
More news about: ESCMID Global
Apr 17, 2026, 18:01 ET ESCMID Global: RSV-Impfung während der Schwangerschaft senkt das Hospitalisierungsrisiko bei Säuglingen um mehr als 80 Prozent, wie eine große UKHSA-Studie zeigt
2024 ein nationales RSV-Impfprogramm für Schwangere eingeführt, in dessen Rahmen Schwangeren ab der 28. Schwangerschaftswoche der bivalente Prefusion-F-Impfstoff angeboten wird.Um die Auswirkungen dieses Programms auf Hospitalisierungen von Säuglingen aufgrund RSV-assoziierter Infektionen der unteren
More news about: ESCMID Global
Apr 17, 2026, 18:01 ET ESCMID Global: vacinação materna contra o VSR reduz o risco de hospitalização infantil em mais de 80%, revela importante estudo da UKHSA
Inglaterra, um programa nacional de vacinação materna contra o VSR foi introduzido em 1º de setembro de 2024, oferecendo a vacina Bivalent Prefusion F a mulheres grávidas a partir de 28 semanas de gestação.Para avaliar seu impacto nas hospitalizações infantis devido a ITRIs associadas ao VSR,
More news about: ESCMID Global
Apr 17, 2026, 18:01 ET La vacunación materna contra el VRS reduce el riesgo de hospitalización infantil en más del 80%
Inglaterra, el 1 de septiembre de 2024 se puso en marcha un programa nacional de vacunación materna contra el VRS, que ofrece la vacuna bivalente Prefusion F a las mujeres embarazadas a partir de las 28 semanas de gestación.Para evaluar su impacto en las hospitalizaciones infantiles por infecciones respiratorias
More news about: ESCMID Global
Apr 17, 2026, 18:01 ET ESCMID Global : la vaccination maternelle contre le VRS réduit de plus de 80% le risque d'hospitalisation des nourrissons, selon une importante étude de l'UKHSA
Angleterre, un programme national de vaccination maternelle contre le VRS a été mis en place le 1er septembre 2024, proposant le vaccin bivalent Prefusion F aux femmes enceintes à partir de 28 semaines de grossesse.Afin d'évaluer son impact sur les hospitalisations de nourrissons dues à une IVRI associée
More news about: ESCMID Global
Apr 17, 2026, 18:01 ET ESCMID Global: La vacunación materna contra el VSR reduce el riesgo de hospitalización infantil en más del 80 %, según un importante estudio de UKHSA
Inglaterra, el 1 de septiembre de 2024 se introdujo un programa nacional de vacunación materna contra el VSR, que ofrece la vacuna Bivalent Prefusion F a mujeres embarazadas a partir de las 28 semanas de gestación.Para evaluar su impacto en las hospitalizaciones infantiles debidas a las IRTI asociadas
More news about: ESCMID Global
Apr 17, 2026, 17:20 ET IsoEnergy Announces New At-The-Market Equity Program
April 17, 2026 (the "U.S. Prospectus Supplement") to the Company's U.S. base prospectus included in its registration statement on Form F-10 (the "Registration Statement") and filed with the U.S. Securities and Exchange Commission (the "SEC") on January 13, 2026.The
More news about: IsoEnergy Ltd.
Apr 17, 2026, 16:39 ET Shanghai Electric vermeldet starke Ergebnisse für 2025, Auftragseingänge erreichen Rekordhoch
und Entwicklungsausgaben in Höhe von 6,164 Mrd. RMB (904,26 Mio. USD) 2025 untermauern die anhaltend hohen Investitionen von Shanghai Electric in F&E weiterhin technologische Innovationen und Produktverbesserungen.Förderung der industriellen Optimierung und der globalen MarktpräsenzAls
More news about: Shanghai Electric
Apr 17, 2026, 16:33 ET Cemig Files 2025 Form 20-F
("B3") and the markets in general that it has registered on April 17, 2026, its Form 20-F for the 2025 fiscal year ("Form 20-F 2025") with the U.S. Securities and Exchange Commission ("SEC"). The 2025 Form 20-F 2025 was filed and is available as of April 17, 2026, at the SEC's website (
More news about: Cemig
Apr 17, 2026, 16:30 ET Hyperscale Data Declares Monthly Cash Dividend of $0.2708333 per Share of 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock
of a newly designated Series F Exchangeable Preferred Stock (the "Series F Preferred Stock") to all common stockholders and holders of the Series C Preferred Stock on an as-converted basis. The Divestiture will occur through the voluntary exchange of the Series F Preferred Stock for shares of
More news about: Hyperscale Data Inc.
Apr 17, 2026, 16:15 ET Bank of America Declares Preferred Stock Dividends Payable in May and June 2026
Floating Rate Non-Cumulative Preferred Stock, Series F
More news about: Bank of America Corporation
Apr 17, 2026, 16:01 ET New Clinical and Preclinical Data for Investigational Candidate Zidesamtinib Presented at AACR Annual Meeting 2026
e Responses also observed in pts with ROS1 D2033N (n=1) and L2086F (n=1).f Includes patients with measurable (≥5mm) CNS lesions by BICR at baseline.The
More news about: Nuvalent, Inc.
Apr 17, 2026, 15:50 ET Nordea Bank Abp: Repurchase of own shares on 17.04.2026
https://mb.cision.com/Public/434/4336643/a31b15f3311a08e6.pdfNordea-statement-of-transactions-in-own-shares-20260417
More news about: Nordea
Apr 17, 2026, 15:43 ET HelloNation Breaks Down Ford Truck Cost Factors, Featuring Expert Car Dealer Sarah Pesek
with used Ford trucks can help determine the best fit for both needs and budget.One of the most recognized models is the Ford F-150. The article notes that the Ford F-150 price for a new model typically starts around $38,000 and can exceed $75,000 depending on features and configuration. These differences
More news about: HelloNation
Apr 17, 2026, 15:29 ET 2026 Infrared Sauna Buyer's Guide: 8 Leading Brands Compared Across Heat, Safety, Warranty, and Design
165°F~140°F~140°F
More news about: Sun Home Saunas
Apr 17, 2026, 15:00 ET Immunitas Presents Phase 1/2a Data Highlighting Anti-Tumor Activity of Novel Immunotherapy IMT-009 at AACR 2026 Annual Meeting
first-in-human, dose escalation (DE) and biomarker cohort expansion (BCE) of IMT-009 (IMT) in advanced cancer and Phase 1b (Ph1b) combination with fruquintinib (F) in microsatellite stable colorectal cancer (MSS CRC)," highlights Phase 1/2a results supporting continued evaluation of IMT-009 as both a monotherapy
More news about: Immunitas Therapeutics, Inc.